Sun Pharma Canada

Sun Pharma Canada is the Canadian subsidiary of Sun Pharmaceutical Industries Ltd., the world's fourth-largest specialty generic pharmaceutical company. The company provides a broad portfolio of high-quality, affordable generic medicines alongside a growing pipeline of specialty branded products. Its primary therapeutic focus in Canada includes dermatology, ophthalmology, and oncology, with flagship products such as Ilumya for plaque psoriasis and Cequa for dry eye disease. Leveraging its parent company's global R&D and manufacturing infrastructure, Sun Pharma Canada serves as a key player in the Canadian healthcare landscape by improving access to essential treatments.